Np mrd loader

Record Information
Version2.0
Created at2021-06-20 21:15:35 UTC
Updated at2021-06-30 00:11:30 UTC
NP-MRD IDNP0038616
Secondary Accession NumbersNone
Natural Product Identification
Common Namesalvileucalin B
Provided ByJEOL DatabaseJEOL Logo
DescriptionSalvileucalin B is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. salvileucalin B is found in Salvia leucantha Cav. salvileucalin B was first documented in 2008 (PMID: 18788744). Based on a literature review a small amount of articles have been published on salvileucalin B (PMID: 20088588) (PMID: 20180530) (PMID: 21174417) (PMID: 21770370).
Structure
Thumb
Synonyms
ValueSource
(+)-Salvileucalin bChEBI
Chemical FormulaC20H14O5
Average Mass334.3270 Da
Monoisotopic Mass334.08412 Da
IUPAC Name(1R,3S,9S,11S,17S)-3-(furan-3-yl)-4,15-dioxahexacyclo[9.6.1.0^{1,9}.0^{2,6}.0^{9,17}.0^{13,17}]octadeca-2(6),7,12-triene-5,14-dione
Traditional Name(1R,3S,9S,11S,17S)-3-(furan-3-yl)-4,15-dioxahexacyclo[9.6.1.0^{1,9}.0^{2,6}.0^{9,17}.0^{13,17}]octadeca-2(6),7,12-triene-5,14-dione
CAS Registry NumberNot Available
SMILES
[H]C1=C([H])C(=C([H])O1)[C@@]1([H])OC(=O)C2=C1[C@@]13C([H])([H])[C@@]4([H])C([H])=C5C(=O)OC([H])([H])[C@@]15[C@]3(C([H])=C2[H])C4([H])[H]
InChI Identifier
InChI=1S/C20H14O5/c21-16-12-1-3-18-6-10-5-13-17(22)24-9-20(13,18)19(18,7-10)14(12)15(25-16)11-2-4-23-8-11/h1-5,8,10,15H,6-7,9H2/t10-,15+,18+,19+,20+/m0/s1
InChI KeyZWSRRRRYHMMHQC-MDOCMBDYSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Salvia leucanthaJEOL database
    • Aoyagi, Y., et al, Org. Lett. 10, 4429 (2008)
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.11ALOGPS
logP1.51ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)12.12ChemAxon
pKa (Strongest Basic)-2.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area65.74 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity86.81 m³·mol⁻¹ChemAxon
Polarizability32.58 ųChemAxon
Number of Rings7ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID28466272
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID66154
Good Scents IDNot Available
References
General References
  1. Aoyagi Y, Yamazaki A, Nakatsugawa C, Fukaya H, Takeya K, Kawauchi S, Izumi H: Salvileucalin B, a novel diterpenoid with an unprecedented rearranged neoclerodane skeleton from Salvia leucantha Cav. Org Lett. 2008 Oct 16;10(20):4429-32. doi: 10.1021/ol801620u. Epub 2008 Sep 13. [PubMed:18788744 ]
  2. Levin S, Nani RR, Reisman SE: Rapid assembly of the salvileucalin B norcaradiene core. Org Lett. 2010 Feb 19;12(4):780-3. doi: 10.1021/ol902848k. [PubMed:20088588 ]
  3. Tantillo DJ: How an enzyme might accelerate an intramolecular Diels-Alder reaction: theozymes for the formation of salvileucalin B. Org Lett. 2010 Mar 19;12(6):1164-7. doi: 10.1021/ol9028435. [PubMed:20180530 ]
  4. Levin S, Nani RR, Reisman SE: Enantioselective total synthesis of (+)-salvileucalin B. J Am Chem Soc. 2011 Feb 2;133(4):774-6. doi: 10.1021/ja110192b. [PubMed:21174417 ]
  5. Tseng CC, Ding H, Li A, Guan Y, Chen DY: A modular synthesis of salvileucalin B structural domains. Org Lett. 2011 Aug 19;13(16):4410-3. doi: 10.1021/ol201748x. Epub 2011 Jul 19. [PubMed:21770370 ]
  6. Aoyagi, Y., et al. (2008). Aoyagi, Y., et al, Org. Lett. 10, 4429 (2008). Org. Lett..